Recent Company News

• 09:23 AM ET Mar 20, 2026
  

  Transcript Intelligence: Cellectis SA Q4 Earnings Guidance

• 09:23 AM ET Mar 20, 2026
  

  Transcript Intelligence: Cellectis SA Q4 Earnings Themes

• 09:23 AM ET Mar 20, 2026
  

  Transcript Intelligence: Cellectis SA Q4 Earnings Q&A

• 07:32 PM ET Mar 19, 2026
  

  Cellectis SA reports Q4 EPS ($0.26) vs FactSet ($0.20) [6 est, ($0.32)-0.04] (€2.97, 0.00)

• 04:41 PM ET Jan 08, 2026
  

  Cellectis SA issues 2026 strategy; first interim analysis of Phase 2 BALLI-01 trial expected to complete in Q4 (€3.95, 0.00)

• 05:09 PM ET Dec 16, 2025
  

  StreetAccount Sector Summary - Healthcare Post-Market

• 08:40 AM ET Dec 23, 2025
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 04:38 PM ET Dec 22, 2025
  

  Cellectis SA initiated buy at Clear Street ($4.69, 0.00)